Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 11Recruiting 7Terminated 2Not yet recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Infertility 2Anovulation 2

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Medroxyprogesterone Acetate × Clear all
NCT01718444 2020-09-29

Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)

University of Illinois at Chicago

Phase NA Terminated
27 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT01607320 2018-09-20

PCOS

Prisma Health-Upstate

Phase NA Terminated
3 enrolled 3 charts

Anovulation, Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡